Stat3 antagonists and their use as vaccines against cancer
AssigneesUniversity of South Florida, The Johns Hopkins University
InventorsHua Yu, Drew Pardoll, Richard Jove
Life of this patent
Estimating the term…
Loading patent…
AssigneesUniversity of South Florida, The Johns Hopkins University
InventorsHua Yu, Drew Pardoll, Richard Jove
Estimating the term…
The present invention relates to methods for treating and/or preventing cancer. In particular the present invention relates to ex vivo immunotherapeutic methods. The methods comprise decreasing Stat3 (signal transducer and activator of transcription3) expression and/or function in tumor cells and the administration of such cells to a subject in need of treatment and/or prevention. Other methods of the invention comprise activating T-cells by co-culturing the T-cells with the tumor cells with decreased Stat3 expression or function. The invention further encompasses methods comprising decreasing Stat3 expression or function in antigen-presenting cells and co-administering tumor cells and the antigen-presenting cells with decreased Stat3 function to a patient. The invention further relates to methods for stimulating dendritic cell differentiation.
A method for treating and/or preventing cancer in a subject, said method comprising:
A method for treating and/or preventing cancer in a subject, said method comprising administering tumor cells to the subject thereby stimulating an immune-response in the subject such that the cancer is treated or prevented, said tumor cells being the product of a method comprising the following steps:
A method for treating and/or preventing cancer in a subject comprising:
A method for treating and/or preventing cancer in a subject comprising administering activated cytotoxic T-cells to the subject, such that the cancer in the subject is treated or prevented, said cytotoxic T-cells being the product of a method comprising:
A method for treating and/or preventing cancer in a subject, said method comprising:
A method for treating and/or preventing cancer in a subject, said method comprising administering the cytotoxic T cells to the subject, such that the cancer in the subject is treated or prevented, said cytotoxic T cells being the product of a method comprising:
A method for treating and/or preventing cancer in a subject, wherein the method comprises:
A method for treating and/or preventing cancer in a subject, wherein the method comprising administering antigen-presenting cells and tumor cells to the subject, thereby stimulating an immune-response in the subject such that the cancer is treated or prevented, said antigen-presenting cells and tumor cells being the product of a method comprising:
A method for stimulating dendritic cell differentiation, said method comprising:
A method for stimulating dendritic cell differentiation, said method comprising:
A method for making an inactivated tumor cell useful for stimulating an immune response comprising:
A method for treating and/or preventing cancer in a subject, wherein the method comprises:
A method for treating and/or preventing cancer in a subject, wherein the method comprises:
A method for treating and/or preventing an infectious disease in a subject, wherein the method comprises:
A method for treating and/or preventing an infectious disease in a subject, wherein the method comprises:
A method for treating and/or preventing an infectious disease in a subject, wherein the method comprises:
A method for treating and/or preventing an infectious disease in a subject, wherein the method comprises administering to the subject an amount of the antigen-presenting cells effective to stimulate an immune response in the subject, wherein the antigen-presenting cells are produced by the following steps:
Dependencies are inferred from the claim text.